Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success
- PMID: 18626679
- PMCID: PMC2660166
- DOI: 10.1007/s00395-008-0737-9
Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success
Abstract
Repetitive cycles of reflow/reocclusion in the initial 2 min following release of a prolonged coronary occlusion, i.e., ischemic postconditioning (IPoC), salvages ischemic myocardium. We have proposed that the intermittent ischemia prevents formation of mitochondrial permeability transition pores (MPTP) by maintaining an acidic myocardial pH for several minutes until survival kinases can be activated. To determine other requisites of IPoC, isolated rabbit hearts were subjected to 30 min of regional myocardial ischemia and 120 min of reperfusion. Infarct size was determined by staining with triphenyltetrazolium chloride. During the first 2 min of reperfusion the perfusate was either at pH 7.4 following equilibration with 95% O(2)/5% CO(2), pH 6.9 following equilibration with 80% N(2)/20% CO(2), or pH 7.8 following equilibration with 100% O(2). Whereas acidic, oxygenated perfusate for the first 2 min of reperfusion was cardioprotective, protection was lost when acidic perfusate was hypoxic. However, the acidic, hypoxic hearts could be rescued by addition of phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, to the perfusate. Therefore, both low pH and restoration of oxygenation are necessary for protection, and the signaling step requiring combined oxygen and H(+) must be upstream of PKC. To gain further insight into the mechanism of IPoC, the latter was effected with 6 cycles of 10-s reperfusion/10-s reocclusion. Its protective effect was abrogated by either making the oxygenated perfusate alkaline during the reperfusion phases or making the reperfusion buffer hypoxic. Presumably the repeated coronary occlusions during IPoC keep myocardial pH low while the resupply of oxygen during the intermittent reperfusion provides fuel for the redox signaling that acts to prevent MPTP formation even after restoration of normal myocardial pH. Hearts treated simultaneously with IPoC and alkaline perfusate could not be rescued by addition to the perfusate of either PMA or SB216763 which inhibits GSK-3beta, the putative last cytoplasmic signaling step in the signal transduction cascade leading to MPTP inhibition. Yet cyclosporin A which also inhibits MPTP formation does rescue hearts made alkaline during IPoC. In view of prior studies in which the ROS scavenger N-2-mercaptopropionyl glycine aborts IPoC's protection, our data reveal that IPoC's reperfusion periods are needed to support redox signaling rather than improve metabolism. The low pH, on the other hand, is equally necessary and seems to suppress MPTP directly rather than through upstream signaling.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2660166/bin/nihms-101227-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2660166/bin/nihms-101227-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2660166/bin/nihms-101227-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2660166/bin/nihms-101227-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2660166/bin/nihms-101227-f0005.gif)
Similar articles
-
The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis.Circulation. 2007 Apr 10;115(14):1895-903. doi: 10.1161/CIRCULATIONAHA.106.675710. Epub 2007 Mar 26. Circulation. 2007. PMID: 17389262
-
Redox signaling at reperfusion is required for protection from ischemic preconditioning but not from a direct PKC activator.Basic Res Cardiol. 2008 Jan;103(1):54-9. doi: 10.1007/s00395-007-0683-y. Epub 2007 Nov 12. Basic Res Cardiol. 2008. PMID: 17999029 Free PMC article.
-
Ischemic postconditioning: from receptor to end-effector.Antioxid Redox Signal. 2011 Mar 1;14(5):821-31. doi: 10.1089/ars.2010.3318. Epub 2010 Aug 30. Antioxid Redox Signal. 2011. PMID: 20518705 Review.
-
Redox signaling triggers protection during the reperfusion rather than the ischemic phase of preconditioning.Basic Res Cardiol. 2008 Jul;103(4):378-84. doi: 10.1007/s00395-008-0718-z. Epub 2008 Mar 17. Basic Res Cardiol. 2008. PMID: 18347834 Free PMC article.
-
The role of mitochondria in protection of the heart by preconditioning.Biochim Biophys Acta. 2007 Aug;1767(8):1007-31. doi: 10.1016/j.bbabio.2007.05.008. Epub 2007 Jun 2. Biochim Biophys Acta. 2007. PMID: 17631856 Free PMC article. Review.
Cited by
-
Initial Despair and Current Hope of Identifying a Clinically Useful Treatment of Myocardial Reperfusion Injury: Insights Derived from Studies of Platelet P2Y12 Antagonists and Interference with Inflammation and NLRP3 Assembly.Int J Mol Sci. 2024 May 17;25(10):5477. doi: 10.3390/ijms25105477. Int J Mol Sci. 2024. PMID: 38791515 Free PMC article. Review.
-
Targeting mitochondrial shape: at the heart of cardioprotection.Basic Res Cardiol. 2023 Nov 13;118(1):49. doi: 10.1007/s00395-023-01019-9. Basic Res Cardiol. 2023. PMID: 37955687 Free PMC article.
-
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.Pharmacol Rev. 2023 Jan;75(1):159-216. doi: 10.1124/pharmrev.121.000348. Epub 2022 Dec 8. Pharmacol Rev. 2023. PMID: 36753049 Free PMC article. Review.
-
Insights into research on myocardial ischemia/reperfusion injury from 2012 to 2021: a bibliometric analysis.Eur J Med Res. 2023 Jan 9;28(1):17. doi: 10.1186/s40001-022-00967-7. Eur J Med Res. 2023. PMID: 36624514 Free PMC article.
-
A Potent Inhibitor of Aminopeptidase P2 Reduces Reperfusion Injury in Models of Myocardial Infarction and Stroke.J Pharmacol Exp Ther. 2022 Mar;380(3):220-229. doi: 10.1124/jpet.121.000875. Epub 2022 Jan 3. J Pharmacol Exp Ther. 2022. PMID: 34980660 Free PMC article.
References
-
- Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D, Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation. 2005;111:194–197. - PubMed
-
- Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res. 2008;102:131–135. - PubMed
-
- Cohen MV, Yang X-M, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation. 2007;115:1895–1903. - PubMed
-
- Förster K, Paul I, Solenkova N, Staudt A, Cohen MV, Downey JM, Felix SB, Krieg T. NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase. Basic Res Cardiol. 2006;101:319–326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources